Rock Springs Capital Management LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$4.3T
Holdings
136
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (136 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $202.4B |
HUMHUMANA INC | $161.9B |
AFWALIGN TECHNOLOGY INC | $131.4B |
ISRGINTUITIVE SURGICAL INC | $129.3B |
PODDINSULET CORP | $123.4B |
UNHUNITEDHEALTH GROUP INC | $120.5B |
IDXXIDEXX LABS INC | $118.5B |
HCAHCA HEALTHCARE INC | $115.6B |
ARGXARGENX SE | $110.3B |
NBIXNEUROCRINE BIOSCIENCES INC | $94.1B |
2L9BLUEPRINT MEDICINES CORP | $92.1B |
AGIOAGIOS PHARMACEUTICALS INC | $87.0B |
IMCRIMMUNOCORE HLDGS PLC | $84.6B |
HZNPHORIZON THERAPEUTICS PUB L | $80.4B |
EWEDWARDS LIFESCIENCES CORP | $75.4B |
RAREULTRAGENYX PHARMACEUTICAL IN | $74.3B |
ZLABZAI LAB LTD | $74.2B |
BAXBAXTER INTL INC | $63.0B |
NVV1NOVAVAX INC | $60.8B |
MRTXEURMIRATI THERAPEUTICS INC | $60.2B |
PCRXPACIRA BIOSCIENCES INC | $60.2B |
NVROEURNEVRO CORP | $57.9B |
EVHEVOLENT HEALTH INC | $56.4B |
ALNYALNYLAM PHARMACEUTICALS INC | $56.4B |
ACRSACLARIS THERAPEUTICS INC | $56.1B |
KRTXKARUNA THERAPEUTICS INC | $55.9B |
FRPTFRESHPET INC | $55.3B |
ASNDASCENDIS PHARMA A/S | $53.8B |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $53.4B |
IRTCIRHYTHM TECHNOLOGIES INC | $51.0B |
KYMRKYMERA THERAPEUTICS INC | $47.1B |
ACHCACADIA HEALTHCARE COMPANY IN | $45.4B |
EXASEXACT SCIENCES CORP | $44.4B |
NVTA1EURINVITAE CORP | $42.8B |
PENPENUMBRA INC | $42.7B |
SWAVUSDSHOCKWAVE MED INC | $39.7B |
SGENUSDSEAGEN INC | $39.6B |
SRPTSAREPTA THERAPEUTICS INC | $38.2B |
ARVNARVINAS INC | $37.6B |
CYTK 4 11/15/26CYTOKINETICS INC | $35.7B |
WRBYWARBY PARKER INC | $33.7B |
HCATHEALTH CATALYST INC | $33.7B |
VERVVERVE THERAPEUTICS INC | $33.3B |
CVETUSDCOVETRUS INC | $33.2B |
EHCENCOMPASS HEALTH CORP | $32.8B |
PHRPHREESIA INC | $32.1B |
PRTAPROTHENA CORP PLC | $32.0B |
ACCDEURACCOLADE INC | $31.6B |
DC4DEXCOM INC | $30.5B |
TVTXTRAVERE THERAPEUTICS INC | $29.5B |
—ABCAM PLC | $29.5B |
CNMDCONMED CORP | $28.7B |
GRPHGRAPHITE BIO INC | $25.8B |
—SIERRA ONCOLOGY INC | $25.8B |
—INTERSECT ENT INC | $25.7B |
MIRMMIRUM PHARMACEUTICALS INC | $24.5B |
—PROMETHEUS BIOSCIENCES INC | $24.5B |
XENEXENON PHARMACEUTICALS INC | $24.1B |
BMRNBIOMARIN PHARMACEUTICAL INC | $23.3B |
MDGLMADRIGAL PHARMACEUTICALS INC | $22.8B |
LUNGPULMONX CORP | $22.4B |
DVAXDYNAVAX TECHNOLOGIES CORP | $22.2B |
WSTWEST PHARMACEUTICAL SVSC INC | $21.3B |
—MERSANA THERAPEUTICS INC | $20.2B |
GHGUARDANT HEALTH INC | $20.0B |
XLOXILIO THERAPEUTICS INC | $19.1B |
LFSTLIFESTANCE HEALTH GROUP INC | $19.0B |
LEGNLEGEND BIOTECH CORP | $18.8B |
ANABANAPTYSBIO INC | $18.7B |
RLAYRELAY THERAPEUTICS INC | $18.4B |
IMRXIMMUNEERING CORP | $17.6B |
AURAAURA BIOSCIENCES INC | $17.1B |
CMPXCOMPASS THERAPEUTICS INC | $16.9B |
—ICOSAVAX INC | $16.8B |
SPROSPERO THERAPEUTICS INC | $15.1B |
GOSS 5 06/01/27GOSSAMER BIO INC | $15.1B |
AMRNAMARIN CORP PLC | $14.9B |
—AMRYT PHARMA PLC | $14.1B |
MGNXMACROGENICS INC | $13.8B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $13.5B |
NVCRNOVOCURE LTD | $13.1B |
WHWKAADI BIOSCIENCE INC | $13.0B |
RIGLUSDRIGEL PHARMACEUTICALS INC | $12.9B |
AKROAKERO THERAPEUTICS INC | $12.4B |
290ACHINOOK THERAPEUTICS INC | $11.7B |
AM6AMICUS THERAPEUTICS INC | $11.7B |
LPTXEURLEAP THERAPEUTICS INC | $11.4B |
ABOSACUMEN PHARMACEUTICALS INC | $10.6B |
AUPHAURINIA PHARMACEUTICALS INC | $10.5B |
CGEMCULLINAN ONCOLOGY INC | $10.0B |
—ORION ACQUISITION CORP | $9.8B |
OKURRENEO PHARMACEUTICALS INC | $9.8B |
—EPIZYME INC | $9.5B |
—OLINK HLDG AB | $9.4B |
NRIXNURIX THERAPEUTICS INC | $9.3B |
MREOMEREO BIOPHARMA GROUP PLC | $8.9B |
BMEABIOMEA FUSION INC | $8.7B |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $8.3B |
—VINCERX PHARMA INC | $8.2B |
FULCFULCRUM THERAPEUTICS INC | $8.1B |
Page 1 of 2Next